查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026772

2034年胃腸支架市場預測－按產品類型、類別、材料、應用、最終用戶和地區分類的全球分析

Gastrointestinal Stents Market Forecasts to 2034 - Global Analysis By Product, Type, Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球胃腸道支架市場規模將達到 6.6 億美元，並在預測期內以 7.6% 的複合年成長率成長，到 2034 年將達到 11.87 億美元。

胃腸道支架是一種用於治療消化器官系統（例如食道、胃和腸道）狹窄或阻塞的醫療設備。這些管狀結構透過內視鏡插入，以提供支撐、緩解阻塞並促進液體和食物的流動。胃腸道支架在治療狹窄、腫瘤和阻塞等疾病方面發揮著至關重要的作用，為手術提供了微創替代方案。

根據 MDPI 出版的《Current Oncology Research》雜誌 2022 年發表的報告，1990 年至 2019 年間，中國男性上消化道癌症病例數為 14,934,040 例，女性為 6,262,431 例，增幅達 181.44%。

胃腸道疾病盛行率增加

隨著大腸直腸癌、發炎性腸道疾病和胃腸道狹窄等胃腸道疾病發病率的迅速上升，對有效治療性介入的需求日益成長，其中胃腸道支架在緩解症狀和改善患者預後方面發揮著至關重要的作用。這些支架有助於恢復正常的消化功能，減輕症狀，並提供微創解決方案。人們對這些疾病的認知不斷提高，以及支架技術的進步，正推動著市場成長，醫療專業人員擴大選擇這些器材來滿足日益成長的胃腸道介入治療需求。

缺乏意識

對消化器官系統疾病及其治療方案缺乏了解會導致診斷和治療延誤。這也會阻礙病患教育以及醫病之間的協作決策，從而可能限制消化系統疾病的治療選擇。從市場角度來看，醫護人員和公眾認知不足會對製造商和供應商促銷產品和擴大市場佔有率帶來挑戰。

客製化和患者特定解決方案的興起

根據患者個別需求客製化胃腸道支架可提高治療效果並最大限度地減少潛在併發症。這一趨勢不僅能解決獨特的解剖結構差異，還能改善患者的整體預後，並推動市場創新和成長。隨著對個人化醫療介入的需求不斷成長，在胃腸道支架領域整合客製化解決方案被視為實現進步和市場擴張的關鍵途徑。

替代治療方法的選擇增多

患者和醫療專業人員可能會選擇藥物治療和微創手術等非支架治療方法，這可能導致對胃腸道支架的需求下降。這種偏好的轉變可能會影響傳統支架製造商的市場佔有率和收入潛力，凸顯了在不斷發展的胃腸道治療領域，企業需要透過創新、提高療效和策略差異化來保持競爭優勢。

新冠疫情的感染疾病

新冠疫情透過擾亂供應鏈、延遲擇期手術以及將醫療資源轉移到危機管理，對胃腸道支架市場造成了衝擊。這些因素導致胃腸道支架的需求暫時下降。然而，隨著醫療系統適應「新常態」以及擇期手術的恢復，市場正在復甦。內視鏡手術的日益普及和支架技術的進步也將推動胃腸道支架市場的未來成長。

在預測期內，自膨式金屬支架細分市場預計將成為最大的細分市場。

自膨式金屬支架市場預計將迎來顯著成長。自膨式金屬支架（SEMS）在胃腸道支架領域發揮至關重要的作用，為多種疾病提供微創治療方法。這些支架由金屬合金製成，植入後可自動擴張，為阻塞或狹窄的胃腸道提供結構支撐。 SEMS 能有效緩解阻塞和狹窄等症狀，進而改善消化功能。其多功能性和適應性使其成為治療食道、結直腸和膽道阻塞等疾病的首選。

在預測期內，胃腸道癌症領域預計將呈現最高的複合年成長率。

預計在預測期內，胃腸道癌症領域將呈現最高的複合年成長率。胃腸道支架在胃腸道癌症的治療中發揮著至關重要的作用，它能夠緩解症狀並提高患者的生活品質。這些支架透過內視鏡手術置入，提供了一種微創解決方案，可以恢復正常功能，並允許食物和液體通過。胃腸道支架具有安寧療護的作用，可以提高患者的舒適度，並有助於簡化治療方案的發展。

市佔率最大的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率，這主要受胃腸道疾病日益普遍和人口老化的影響。中國、日本和印度等國家對市場成長做出了顯著貢獻。波士頓科學公司、Medtronic和雅培公司等領導企業均位於該地區。對微創手術的需求以及大腸直腸癌等疾病發病率的上升正在推動該地區胃腸道支架的應用。隨著醫療基礎設施的改善和對有效胃腸道治療需求的不斷成長，預計該市場將繼續擴張。

複合年成長率最高的地區：

由於阻塞性胃腸道疾病盛行率不斷上升、有利的醫保報銷政策以及人口老化，預計北美在預測期內將呈現最高的複合年成長率。北美是醫療設備產業最發達的市場之一。此外，低成本的先進醫療服務正在推動該地區醫療旅遊業的快速發展，預計這將擴大該地區的患者群體。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球胃腸支架市場：依產品分類

  • 十二指腸支架
  • 膽道支架
  • 胰管支架
  • 結腸支架
  • 食道支架

第6章 全球胃腸道支架市場：按類型分類

  • 移動預防支架
  • 放射性支架
  • 藥物釋放型支架
  • 防回流支架
  • 可變形支架
  • 其他類型

第7章：全球胃腸支架市場：依材料分類

  • 自膨式金屬支架
  • 塑膠支架
  • 其他材料

第8章 全球胃腸支架市場：依應用分類

  • 胃癌
  • 大腸激躁症
  • 胰臟癌
  • 結腸癌
  • 胃腸道癌症
  • 食道癌
  • 膽道疾病
  • 其他用途

第9章 全球胃腸支架市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第10章 全球胃腸支架市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第11章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • Boston Scientific Corporation
  • Hobbs Medical Inc.
  • General Electric Company
  • Cantel Medical Corporation
  • Olympus Corporation
  • Merit Medical Systems
  • Qualimed
  • Medtronic
  • Conmed Corporation
  • Terumo Corporation
  • Johnson & Johnson
  • The 3M Company
  • Smith & Nephew
  • Diagmed Healthcare
  • Medline Industries
  • Baxter
  • B. Braun Melsungen AG
  • Danaher Corporation
Product Code: SMRC24635

According to Stratistics MRC, the Global Gastrointestinal Stents Market is accounted for $660.0 million in 2026 and is expected to reach $1,187.0 million by 2034 growing at a CAGR of 7.6% during the forecast period. Gastrointestinal stents are medical devices used to treat narrowed or blocked passages within the digestive system, such as the esophagus, stomach, or intestines. These tubular structures are inserted endoscopically to provide support, relieve obstruction, and facilitate the flow of fluids or food. Gastrointestinal stents play a crucial role in managing conditions like strictures, tumours, or obstructions, offering a minimally invasive alternative to surgery.

According to published report of 2022 in current oncology research article of MDPI publisher, reported upper gastrointestinal cancer incidences in China were 14,934,040 cases of male and 6,262,431 cases of female with growth rate 181.44% in between 1990 to 2019.

Market Dynamics:

Driver:

Increasing prevalence of gastrointestinal disorders

The escalating prevalence of gastrointestinal disorders, such as colorectal cancer, inflammatory bowel disease, and gastrointestinal strictures necessitates effective therapeutic interventions, where gastrointestinal stents play a crucial role in providing relief and improving patient outcomes. These stents facilitate the restoration of normal digestive function, alleviate symptoms, and offer minimally invasive solutions. The growing awareness of these disorders, coupled with advancements in stent technologies, further propels market growth as healthcare professionals increasingly opt for these devices to address the surging demand for gastrointestinal interventions.

Restraint:

Lack of awareness

Lack of awareness about gastrointestinal issues and available treatment options may lead to delayed diagnosis and treatment. It can hinder patient education and shared decision-making between healthcare providers and patients, limiting the choices available for managing gastrointestinal conditions. From a market perspective, manufacturers and suppliers may face challenges in promoting their products and expanding their market share if there is insufficient awareness among both healthcare professionals and the general public.

Opportunity:

Rising customized & patient-specific solutions

Tailoring gastrointestinal stents to individual patient needs enhances treatment efficacy and minimizes potential complications. This trend not only addresses unique anatomical variations but also improves overall patient outcomes, driving innovation and growth within the market. As demand for personalized medical interventions continues to rise, the integration of customized solutions in the gastrointestinal stents sector positions itself as a key avenue for advancement and market expansion.

Threat:

Availability of alternative treatment options

Patients and healthcare providers may opt for non-stent interventions, such as medications or minimally invasive procedures, reducing the demand for gastrointestinal stents. This shift in preferences could impact the market share and revenue potential for traditional stent manufacturers, emphasizing the need for innovation, improved efficacy, and strategic differentiation to maintain a competitive edge in the evolving landscape of gastrointestinal treatments.

Covid-19 Impact

The covid-19 pandemic has impacted the Gastrointestinal Stents Market by causing disruptions in the supply chain, delaying elective procedures, and diverting healthcare resources to manage the crisis. These factors have led to a temporary decline in the demand for gastrointestinal stents. However, as healthcare systems adapt to the new normal and elective procedures resume, the market has recovered. The increased focus on endoscopic procedures and advancements in stent technology also drive future growth in the gastrointestinal stents market.

The self-expanding metal stents segment is expected to be the largest during the forecast period

The self-expanding metal stents segment is estimated to have a lucrative growth. Self-expanding metal stents (SEMS) play a pivotal role in Gastrointestinal Stents, offering a minimally invasive solution for various conditions. Composed of metal alloys, these stents automatically expand upon deployment, providing structural support to obstructed or narrowed gastrointestinal passages. SEMS effectively alleviate symptoms, such as blockages or strictures, enabling improved digestive function. Their versatility and adaptability make them a preferred choice for treating conditions like esophageal, colorectal, and biliary obstructions.

The gastrointestinal cancers segment is expected to have the highest CAGR during the forecast period

The gastrointestinal cancers segment is anticipated to witness the highest CAGR growth during the forecast period. Gastrointestinal stents play a crucial role in managing gastrointestinal cancers by alleviating symptoms and improving the quality of life for patients. Deployed through endoscopic procedures, these stents provide a minimally invasive solution, restoring proper functioning and enabling the passage of food and fluids. Gastrointestinal stents serve as palliative care, enhancing patient comfort and facilitating treatment plans.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising gastrointestinal disorders and an aging population. Countries like China, Japan, and India are prominent contributors to the market's growth. It is home for major key players such as Boston, Medtronic and Abbott Laboratories. The demand for minimally invasive procedures and a growing prevalence of diseases such as colorectal cancer are fueling the adoption of gastrointestinal stents in the region. The market is poised for continued expansion as healthcare infrastructure improves and the need for effective gastrointestinal interventions rises.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of obstructive gastrointestinal diseases, favourable reimbursement policies and aging population. North America is one of the most developed medical device industries market. Further, the booming medical tourism industry in the region owing to availability of the advanced medical treatments at a cheaper cost is anticipated to expand the patient base in the region.

Key players in the market

Some of the key players profiled in the Gastrointestinal Stents Market include Boston Scientific Corporation, Hobbs Medical Inc., General Electric Company, Cantel Medical Corporation, Olympus Corporation, Merit Medical Systems, Qualimed, Medtronic, Conmed Corporation, Terumo Corporation, Johnson & Johnson, The 3M Company, Smith & Nephew, Diagmed Healthcare, Medline Industries, Baxter, B. Braun Melsungen AG and Danaher Corporation.

Key Developments:

In November 2020, Boston Scientific Corporation (US) has received 510(k) approval from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures caused by esophageal cancer.

In October 2020, Olympus Corporation (Japan) launched HANAROSTENT Esophagus TTS Self-expanding Metal Stents (SEMS) made by MI-Tech and distributed exclusively through Olympus in the US.

Products Covered:

  • Duodenal Stent
  • Biliary Stent
  • Pancreatic Stent
  • Colonic Stent
  • Esophageal Stent

Types Covered:

  • Anti-Migratory Stents
  • Radioactive Stents
  • Drug-Eluting Stents
  • Anti-Reflux Stents
  • Shape-Modified Stents
  • Other Types

Materials Covered:

  • Self-Expanding Metal Stents
  • Plastic Stents
  • Other Materials

Applications Covered:

  • Stomach Cancer
  • Irritable Bowel Syndrome
  • Pancreatic Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancers
  • Esophageal Cancer
  • Biliary Diseases
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gastrointestinal Stents Market, By Product

  • 5.1 Introduction
  • 5.2 Duodenal Stent
  • 5.3 Biliary Stent
  • 5.4 Pancreatic Stent
  • 5.5 Colonic Stent
  • 5.6 Esophageal Stent

6 Global Gastrointestinal Stents Market, By Type

  • 6.1 Introduction
  • 6.2 Anti-Migratory Stents
  • 6.3 Radioactive Stents
  • 6.4 Drug-Eluting Stents
  • 6.5 Anti-Reflux Stents
  • 6.6 Shape-Modified Stents
  • 6.7 Other Types

7 Global Gastrointestinal Stents Market, By Material

  • 7.1 Introduction
  • 7.2 Self-Expanding Metal Stents
  • 7.3 Plastic Stents
  • 7.4 Other Materials

8 Global Gastrointestinal Stents Market, By Application

  • 8.1 Introduction
  • 8.2 Stomach Cancer
  • 8.3 Irritable Bowel Syndrome
  • 8.4 Pancreatic Cancer
  • 8.5 Colorectal Cancer
  • 8.6 Gastrointestinal Cancers
  • 8.7 Esophageal Cancer
  • 8.8 Biliary Diseases
  • 8.9 Other Applications

9 Global Gastrointestinal Stents Market, By End User

  • 9.1 Introduction
  • 9.2 Ambulatory Surgical Centers
  • 9.3 Hospitals
  • 9.4 Specialty Clinics

10 Global Gastrointestinal Stents Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Boston Scientific Corporation
  • 12.2 Hobbs Medical Inc.
  • 12.3 General Electric Company
  • 12.4 Cantel Medical Corporation
  • 12.5 Olympus Corporation
  • 12.6 Merit Medical Systems
  • 12.7 Qualimed
  • 12.8 Medtronic
  • 12.9 Conmed Corporation
  • 12.10 Terumo Corporation
  • 12.11 Johnson & Johnson
  • 12.12 The 3M Company
  • 12.13 Smith & Nephew
  • 12.14 Diagmed Healthcare
  • 12.15 Medline Industries
  • 12.16 Baxter
  • 12.17 B. Braun Melsungen AG
  • 12.18 Danaher Corporation

List of Tables

  • Table 1 Global Gastrointestinal Stents Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Gastrointestinal Stents Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Gastrointestinal Stents Market Outlook, By Duodenal Stent (2023-2034) ($MN)
  • Table 4 Global Gastrointestinal Stents Market Outlook, By Biliary Stent (2023-2034) ($MN)
  • Table 5 Global Gastrointestinal Stents Market Outlook, By Pancreatic Stent (2023-2034) ($MN)
  • Table 6 Global Gastrointestinal Stents Market Outlook, By Colonic Stent (2023-2034) ($MN)
  • Table 7 Global Gastrointestinal Stents Market Outlook, By Esophageal Stent (2023-2034) ($MN)
  • Table 8 Global Gastrointestinal Stents Market Outlook, By Type (2023-2034) ($MN)
  • Table 9 Global Gastrointestinal Stents Market Outlook, By Anti-Migratory Stents (2023-2034) ($MN)
  • Table 10 Global Gastrointestinal Stents Market Outlook, By Radioactive Stents (2023-2034) ($MN)
  • Table 11 Global Gastrointestinal Stents Market Outlook, By Drug-Eluting Stents (2023-2034) ($MN)
  • Table 12 Global Gastrointestinal Stents Market Outlook, By Anti-Reflux Stents (2023-2034) ($MN)
  • Table 13 Global Gastrointestinal Stents Market Outlook, By Shape-Modified Stents (2023-2034) ($MN)
  • Table 14 Global Gastrointestinal Stents Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 15 Global Gastrointestinal Stents Market Outlook, By Material (2023-2034) ($MN)
  • Table 16 Global Gastrointestinal Stents Market Outlook, By Self-Expanding Metal Stents (2023-2034) ($MN)
  • Table 17 Global Gastrointestinal Stents Market Outlook, By Plastic Stents (2023-2034) ($MN)
  • Table 18 Global Gastrointestinal Stents Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 19 Global Gastrointestinal Stents Market Outlook, By Application (2023-2034) ($MN)
  • Table 20 Global Gastrointestinal Stents Market Outlook, By Stomach Cancer (2023-2034) ($MN)
  • Table 21 Global Gastrointestinal Stents Market Outlook, By Irritable Bowel Syndrome (2023-2034) ($MN)
  • Table 22 Global Gastrointestinal Stents Market Outlook, By Pancreatic Cancer (2023-2034) ($MN)
  • Table 23 Global Gastrointestinal Stents Market Outlook, By Colorectal Cancer (2023-2034) ($MN)
  • Table 24 Global Gastrointestinal Stents Market Outlook, By Gastrointestinal Cancers (2023-2034) ($MN)
  • Table 25 Global Gastrointestinal Stents Market Outlook, By Esophageal Cancer (2023-2034) ($MN)
  • Table 26 Global Gastrointestinal Stents Market Outlook, By Biliary Diseases (2023-2034) ($MN)
  • Table 27 Global Gastrointestinal Stents Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 28 Global Gastrointestinal Stents Market Outlook, By End User (2023-2034) ($MN)
  • Table 29 Global Gastrointestinal Stents Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 30 Global Gastrointestinal Stents Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 31 Global Gastrointestinal Stents Market Outlook, By Specialty Clinics (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.